 NESS ZIONA, Israel, Aug. 04, 2021 GLOBE NEWSWIRE -- Sol-Gel Technologies, Ltd. NASDAQ: SLGL, a dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced financial results for the second quarter ended June 30, 2021 and provided an overview of recent corporate developments. 